Wednesday, July 8, 2026

pharma · IC - Interstitial Cystitis · Interstitial Cystitis · LIPO

LIPELLA PHARMACEUTICALS

LIPELLA PHARMACEUTICALS patent portfolio — 4 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Pittsburgh, USA HQ
2005 Founded
3 Employees
Public company Type
LIPO · NYSE Ticker
Company details
Status
Public
HQ
Pittsburgh, USA
Founded
2005
Employees
3
Programs
4
Drugs
3
Patents
4
Intelligence · Patents

LIPELLA PHARMACEUTICALS patents

4 pharmaceutical patents indexed for LIPELLA PHARMACEUTICALS. 0 expire within 24 months.

LIPELLA PHARMACEUTICALS has 4 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 12326492

    Systems and methods of detecting interstitial cystitis

    Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 12138345

    Delivery of agents using metastable liposomes

    Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 11357725

    Delivery of agents using metastable liposomes

    Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 10639278

    Delivery of agents using metastable liposomes

    Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does LIPELLA PHARMACEUTICALS have?

4 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do LIPELLA PHARMACEUTICALS patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.